ERK1/2 anticorps (C-Term)
Aperçu rapide pour ERK1/2 anticorps (C-Term) (ABIN2306522)
Antigène
Voir toutes ERK1/2 (MAPK1/3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 324-345, C-Term
-
Réactivité croisée
- Chien, Humain, Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Ca Hu Mo Rt
-
Attributs du produit
- MAP Kinase p44/42 (MAPK3/MAPK1, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, Mapk, ERT1, Extracellular Signal-regulated Kinase 2, ERK-2, MAP Kinase Isoform p42, p42-MAPK, Mitogen-activated Protein Kinase 2, MAP Kinase 2, MAPK 2, ERK2, PRKM1 / Mitogen-activated Protein Kinase 3, MAP Kinase 3, MAPK 3, ERT2, Extracellular Signal-regulated Kinase 1, ERK-1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, p44-MAPK, Microtubule-associated Protein 2 Kinase, MNK1, p44-ERK1, ERK1, PRKM3)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide (aa324-345) corresponding to a segment near the C-terminus of rat ERK1.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.4, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ERK1/2 (MAPK1/3) (Mitogen-Activated Protein Kinase 1/3 (MAPK1/3))
-
Autre désignation
- MAP Kinase p44/42
Antigène
-